🟢 Grifols is trading 4.25% up today on continued idiosyncratic strength

Grifols is trading at $8.34 (+4.25%) in pre-market, extending its upward momentum following a 3.23% gain on July 28.

• The move appears driven by stock-specific buying interest rather than a headline event, as no clear company-specific catalyst has been identified.
• Grifols is significantly outperforming the broader market and the biotech sector, which has recently shown relative weakness.
• The price action suggests sustained idiosyncratic strength as the stock continues to decouple from broader sector trends.